baber/WOPTO huggingface dataset:
Patent CA-3098601-A1 (CA)
Inventor: COELINGH BENNINK HERMAN JAN TIJMEN
IPC: A61P35/00
Filed: 2019-05-01
Abstract: The invention relates to the treatment of advanced estrogen receptor positive breast cancer in a subject who has been treated with an estrogen activity suppressor selected from a selective estrogen receptor modulator (SERM), an aromatase inhibitor and an anti-estrogen, said treatment comprising administration of an estetrol componentafter the treatment with an estrogen activity suppressor has been discontinued, said estetrol component being selected from estetrol, prodrugs of estetrol and combinations thereof.
Patent CA-3099091-A1 (CA)
Title: Packing material cartridge
Inventor: MAHONEY PHILIP MICHAEL
IPC: F16J15/16
Filed: 2019-03-25
Abstract: A method of forming a packing cartridge from a plurality of packing components comprising placing a plurality of individual packing components in a stacked manner in a die tool assembly and compressing the plurality of packing components in opposite directions to form the packing cartridge. The plurality of packing components forming the packing cartridge are mechanically linked together.
Patent CA-3099100-A1 (CA)
Inventor: BUCKER MARCEL
IPC: B29C70/00
Filed: 2019-06-07
Abstract: The invention relates to a production device and method for producing a spider having one or a plurality of continuous fibre bundles. The production device having a plurality of deflecting devices on the wheel rim side and a plurality of deflecting devices on the hub side, both arranged around an interior of an arrangement from the deflecting devices. In a first step a continuous fibre bundle is wound around at least a part of the deflecting devices on the wheel rim side as a fibre winding, and in a second step at least a part of the deflecting devices on the hub side is displaced in the direction of the interior of the arrangement, such that spokes are formed from parts of the fibre winding which form the at least one part of a closed spider. The invention enables greater flexibility in the production of different types of spoke stars.
Patent CA-3106253-A1 (CA)
Title: Conveyor
Inventor: FUJIO YOSHIHIKO
IPC: B65G47/53
Filed: 2021-01-20
Abstract: A conveyor 10 conveys a tray 91 along a transportation path 20 including a linear path 21 and a curved path 22 connected to the linear path 21. The conveyor 10 includes an orientation assist member 30 configured to assist a change of the conveyance orientation of the tray 91 when the tray 91 is conveyed from the linear path 21 to the curved path 22. The orientation assist member 30 is provided on the linear path 21 on the upstream side of conveyance from a starting position S of the curved path 22 on the transportation path 20.
Patent CA-3107315-A1 (CA)
Inventor: XAVIER BEN
IPC: G16H20/17
Filed: 2019-07-12
Abstract: The present disclosure is directed to management and use of drug libraries in a networked clinical environment. The clinical environment may include various types and/or versions of infusion pumps. An infusion pump operates using a drug library that describes the medications available for administration, rules for administration of the medications, clinical care areas in which the pump may operate, and the like. Different types or versions of infusion pumps may be configured to use different formats of drug library data. In addition, drug library data may be archived to maintain a history of changes.
Patent CA-3107667-A1 (CA)
Inventor: BENNETT KRISTIN
IPC: A61P37/08
Filed: 2019-07-26
Abstract: Systems and containers for organizing and administering an oral immunotherapy regimen to a patient are disclosed herein. One aspect of the present technology is directed systems for efficiently and safely identifying pre-packaged dose units to administer to a patient undergoing oral immunotherapy. Further aspects of the present technology are directed to reducing medical staff dosing errors when administering an oral immunotherapy regimen. In one embodiment, the system includes a plurality of dosage containers, wherein each dosage container includes dosage identification characteristics corresponding to dosage of an oral immunotherapy composition. Further aspects of the present technology are directed to methods of dispensing an oral immunotherapy composition to a patient in a manner that mitigates the risk of errors in oral immunotherapy dose administration.
Patent CA-3110684-A1 (CA)
Title: Adjustable strut assemblies for external fixation systems
Inventor: MULLANEY MICHAEL W
IPC: F16B7/00
Filed: 2019-08-29
Abstract: Length-adjustable strut assemblies for external fixation systems, and corresponding external fixation systems, are disclosed. The strut assemblies include an elongate first and second end members, an elongate intermediate member, and first and second adjustment mechanisms. The intermediate member comprises a threaded rod fixedly coupled within an axial cavity thereof, and is rotatably fixed and axially translatably within an axial cavity of the first end member. An end portion of the second end member is received within the axial cavity of the intermediate member, and the second end member comprises an axial cavity threadably coupled with the threaded rod. The first adjustment mechanism is configured to selectively axially fix the intermediate member relative to the first end member. The second adjustment mechanism is configured to selectively rotate the second end member with respect to the threaded rod to axially translate the second end member relative to the intermediate member.
Patent CA-3110790-A1 (CA)
Inventor: PUDDUCK CHRISTIAN
IPC: G01N27/403
Filed: 2019-08-19
Abstract: Improved analyte detection system within a blood gas analyzer, the improved system comprising and/or consisting of at least one CO-oximetry system that is formed as an integrated, unitary structure(s) with an electrochemical sensor module, and methods of use related thereto.
Patent CA-3114308-A1 (CA)
Title: Reactor for producing a synthesis gas from a fuel
Inventor: LUCAS JANJA ARJAN
IPC: B01J8/18
Filed: 2019-10-01
Abstract: A reactor for producing a synthesis gas from a fuel, with a housing (2) with a combustion part accommodating a first fluidized bed in operation, a riser (3) extending along a longitudinal direction of the reactor (1) and accommodating a second fluidized bed in operation,a down-comer (4) positioned parallel to the riser and extending into the first fluidized bed, and one or more feed channels (33) for providing the fuel to the reactor(1). The reactor (1) further has a riser air chamber section (B) connected to a lower part of the riser (3), the riser air chamber section (B) comprising a cylindrical wall (28) with a plurality of circumferentially located holes (24, 25).
Patent CA-3115186-A1 (CA)
Inventor: ZUIDEMA JOHAN
IPC: A61K9/16
Filed: 2019-10-02
Abstract: The present disclosure relates to extended release dosage forms of human chorionic gonadotropin (h CG) or derivatives or isoforms thereof. The extended release h CG dosage forms comprise biodegradable polymer microspheres and provide for extended release of h CG over a desired time period.
Patent CA-3118259-A1 (CA)
Inventor: SENGUPTA SRIKUMAR
IPC: C12N5/10
Filed: 2013-02-21
Abstract: A method for producing mature hepatocytes having functional hepatic enzyme activity from human pluripotent cells is disclosed. The method includes the step of transferring an external vector comprising the DNA sequence coding for a microRNA having the seed sequence of the microRNA miR-122, the DNA sequence coding for a microRNA having the seed sequence of the microRNA miR-let-7c, a microRNA having the seed sequence of the microRNA miR-122, a microRNA having the seed sequence of the microRNA miR-let-7c, or a combination thereof into one or more fetal hepatocytes. The resulting cells differentiate into mature hepatocytes that exhibit functional hepatic enzyme activity, and can be used in drug metabolism and toxicity testing, in the study of viruses that target hepatic tissue, and as therapeutics. A related method of maintaining the functional hepatic enzyme activity of primary hepatocytes over time is also disclosed. The method includes the step of transferring an external vector comprising the DNA sequence coding for a microRNA having the seed sequence of the microRNA miR-122 into one or more cultured primary hepatocytes.
Patent CA-3119681-A1 (CA)
Title: Automatic selective control valve (svc) configuration detection, and operation assignment, directionality confirmation, and calibration for towable implements towable by work vehicles
Inventor: KALE MANDAR M
IPC: G05B19/042
Filed: 2021-05-26
Abstract: Systems and methods provide automatic assignment of control of a plurality of hydraulic circuits of an associated work vehicle to a plurality of operation systems of an implement. A hydraulic circuit assignment control unit includes a processor, a memory device, logic stored in the memory device, and a communication circuit operatively coupled with the processor. The processor executes the logic to associate an activation of a first hydraulic circuit of the plurality of hydraulic circuits of the associated work vehicle with a physical exercise of an operation system of the plurality of operation systems of the associated implement, and generates pairing assignment data representative of the association of the activated first hydraulic circuit with the physical exercise of the operation system of the implement.  The logic generates directionality confirmation and calibration data that is communicated to the plurality of operation systems with the pairing assignment data.
Patent CA-3120769-A1 (CA)
Title: Dispenser monitoring system
Inventor: TRAMONTINA PAUL F
IPC: A47K5/06
Filed: 2019-11-30
Abstract: A dispensing system for dispensing consumable product comprising a dispenser including a body comprising a front side and a back side, and a product holding area defined by the front side and the back side, wherein the product storage area is configured to store the consumable product within the dispenser; a dispensing mechanism operatively coupled to the consumable product through a consumable product holder in the product storage area, and wherein the dispensing mechanism is configured to facilitate a dispensing cycle to dispense a portion of the consumable product; a first impact sensor configured to sense a first impact to the dispenser; a dispenser event sensor configured to sense an operational status of the dispenser; and a data processing device configured to store impact data describing the first impact and operational status data describing the operational status and associate the first impact data and the operational status data.
Patent CA-3121460-A1 (CA)
Title: D-psicose crystal and preparation method therefor
Inventor: PARK YOUNG SOO
IPC: C07H1/00
Filed: 2019-11-29
Abstract: The present application relates to a method for preparing a D-psicose crystal comprising 98%(w/w) or more of D-psicose and 0.05%(w/w) or less of ethanol on the basis of 100%(w/w) of the entire crystal, the method comprising: a first step of mixing an organic solvent and a solution containing D-psicose; and a second step of injecting a seed into the mixture solution obtained in the first step, and then cooling same, thereby obtaining a maskette comprising a D-psicose crystal. Therefore, the present invention can improve the yield of D-psicose crystals from a D-psicose solution, and can prepare D-psicose crystals having no offensive taste/odor and having a sufficient size and an appropriate shape for mass production.
Patent CA-3122015-A1 (CA)
Inventor: SCHLACK STEFAN
IPC: D06F39/02
Filed: 2019-12-05
Abstract: L'invention concerne un dispositif (1) destiné au dosage de détergent, en particulier de détergent en poudre, qui comprend un boîtier (3) présentant au moins une première zone de réception (5), ladite au moins une zone de réception (5) étant conçue pour accueillir un premier contenant (9) destiné à un détergent, un dispositif de dosage (29) pour le dosage du détergent, ledit dispositif de dosage (29) comportant un réglage de dosage pour le dosage de détergent, qui dépend d'un poids déterminé d'un linge à laver, la première zone de réception (5) comportant une zone de réception de dispositif de dosage (27) destinée à accueillir le dispositif de dosage (29), et un dispositif d'actionnement et/ou d'entraînement (39) pour le dispositif de dosage (29) étant placé dans la zone de réception de dispositif de dosage (27).
Patent CA-3122485-A1 (CA)
Inventor: HAN XIANGMIN
IPC: C08K5/10
Filed: 2014-03-14
Abstract: Il est décrit un mélange polymère pouvant mousser qui comprend une composition polymère et au moins un gonflant. Le gonflant peut comprendre tous gonflants connus pour ne pas appauvrir l'ozone ou augmenter la prévalence du réchauffement de la planète, tels que CO2, HFO, HFC et des mélanges de ceux-ci. Le mélange polymère pouvant mousser peut en outre comprendre au moins un auxiliaire de traitement comprenant une matière de changement de phase organique. Le mélange pouvant former une mousse de la présente est capable de traiter à une plage de pression de 56 à 84 kg/cm2 (de 800 à 1 200 lb/po2) [de 5,5 à 8,3 mégapascals].
Patent CA-3123523-A1 (CA)
Title: Safety razor
Inventor: JANTZI BRAD
IPC: B26B21/14
Filed: 2021-06-28
Abstract: A safety razor including a handle; a base plate having an upper surface; and a top cap having a lower surface. The top cap configured to be secured to the base plate to hold a removeable double-edged razor blade between the upper surface and the lower surface, with the handle extending from the joined base plate and top cap for use in manipulating the joined base plate and top cap.
Patent CA-3125433-A1 (CA)
Title: Method and apparatus for manufacturing a consumable unit for an inhalation device, and a consumable unit for an inhalation device
Inventor: BRAY ANDREW JONATHAN
IPC: A24F40/42
Filed: 2020-01-21
Abstract: A method of manufacturing a consumable unit for use with an inhalation device is disclosed. The method comprises providing a dose of aerosolisable material to a container of the consumable unit; positioning a closure over an end of the container; and securing the closure to the container. Apparatus for manufacturing a consumable unit for use with an inhalation device is also disclosed.
Patent CA-3127090-A1 (CA)
Title: Dual stem cell therapy for neurological conditions
Inventor: LAUGHLIN MARY
IPC: A61K35/28
Filed: 2020-01-17
Abstract: Compositions and methods for treating neuronal injury, such as in Parkinson's disease, comprising administration of hematopoietic stem cells and mesenchymal stromal cells to a subject are provided. Methods for producing such compositions from blood, including umbilical cord blood are also provided.
Patent CA-3127862-A1 (CA)
Title: Compositions for controlling phytoplankton contamination
Inventor: HAREL MOSHE
IPC: C02F1/50
Filed: 2020-01-30
Abstract: A composition for mitigating, inhibiting, ameliorating and/or eliminating phytoplankton growth in a waterbody, the composition comprising an active ingredient at concentration of 80.0-99.5% (w/w) of the composition and a coating material at concentration of 0.5-20% (w/w) of the composition; wherein the critical surface tension of the composition is between 15-60 dyn/cm and wherein the relative density of the composition, prior to being submerged in water, is above 1 g/cm3.
Patent CA-3129616-A1 (CA)
Inventor: TOMASEK ADRIAN
IPC: G10L19/005
Filed: 2020-02-12
Abstract: L'invention concerne un processeur d'émetteur audio destiné à générer une trame protégée contre les erreurs à l'aide de données audio codées d'une trame audio, les données audio codées de la trame audio comprenant une première quantité d'unités d'informations et une seconde quantité d'unités d'informations, comprenant : un organe de construction de trame (506) permettant de construire une trame de mots de code (CW) ayant une matrice de mots de code (CW) définissant des positions de référence d'un nombre total prédéfini de mots de code, l'organe de construction de trame (506) étant configuré pour écrire les unités d'informations de la première quantité d'unités d'informations en commençant à des positions de référence d'un premier sous-ensemble prédéfini des mots de code ; et pour écrire les unités d'informations de la seconde quantité d'unités d'informations en commençant à des positions de référence d'un second sous-ensemble prédéfini des mots de code, l'organe de construction de trame (506) étant configuré pour déterminer une délimitation entre la première quantité d'unités d'informations et la seconde quantité d'unités d'informations de sorte qu'une unité d'informations de commencement de la seconde quantité d'unités d'informations coïncide avec une délimitation de mots de code ; et un codeur de protection contre les erreurs (508) permettant de traiter un ou plusieurs des mots de code du premier sous-ensemble prédéfini des mots de code pour obtenir un premier résultat de traitement ou de traiter un ou plusieurs des mots de code du second sous-ensemble prédéfini des mots de code pour obtenir un second résultat de traitement, et d'ajouter le premier résultat de traitement ou le second résultat de traitement au nombre prédéfini de mots de code pour obtenir une pluralité de mots de code traités représentant la trame protégée contre les erreurs, ou de traiter les mots de code du premier sous-ensemble prédéfini des mots de code ou du second sous-ensemble prédéfini des mots de code individuellement pour obtenir une pluralité de mots de code traités représentant la trame protégée contre les erreurs.
Patent CA-3130521-A1 (CA)
Inventor: ALLWARDT THEODORE E
IPC: G07C5/00
Filed: 2014-07-02
Abstract: Disclosed is a data recording unit and data recording system for use in connection with a vehicle, such as a train, a locomotive of a train, a railcar of a train, and the like.
Patent CA-3131145-A1 (CA)
Title: Monogenic or polygenic disease model organisms humanized with two or more genes
Inventor: HOPKINS CHRISTOPHER
IPC: C12N15/90
Filed: 2020-02-21
Abstract: The present disclosure provides transgenic non-human animal (e.g., nematode) systems for assessing heterologous polygenic or monogenic phenotypes, their variants and drug discovery. The transgenic non-human animals (e.g., nematodes) contain a first heterologous polypeptide coding sequence and a second heterologous polypeptide coding sequence (a plurality of heterologous polypeptide coding sequences), wherein the first and second heterologous polypeptide coding sequences are integrated into the host animal genome, and wherein expression of the first and second heterologous polypeptide coding sequence contribute to the heterologous phenotype. The plurality of heterologous polypeptide coding sequences are interrelated wherein their expression products, directly or indirectly, contribute or lead to an observable phenotype.
Patent CA-3131677-A1 (CA)
Inventor: YAKOVLEVA MARINA
IPC: H01M4/04
Filed: 2019-09-18
Abstract: A substrate coated with a printable lithium composition is provided. The printable lithium composition includes lithium metal powder; a polymer binder, wherein the polymer binder is compatible with the lithium powder; and a rheology modifier compatible with the lithium powder and the polymer binder, wherein the rheology modifier is dispersible within the composition and provides a three-dimensional support structure for further improvement of the electrochemical performance of the electrode when coated with the composition. The substrate may be incorporated into a battery. In one embodiment, the battery comprises a cathode, an electrolyte and an anode, wherein the cathode, the electrolyte, the separator, the anode, or a combination thereof may each comprise a substrate coated with a printable lithium composition.
Patent CA-3132392-A1 (CA)
Title: Rare-earth-manganese/cerium-zirconium-based composite compound, method for preparing same and use thereof
Inventor: HUANG XIAOWEI
IPC: B01D53/56
Filed: 2020-09-04
Abstract: A rare earth manganese/cerium-zirconium-based composite compound, a preparation method therefor and an application thereof. The composite compound has a core-shell structure, which is as represented by a general formula: ARE cB aO b-(1-A)Ce xZr (1-x-y)M yO 2-z, wherein 0.1=A=0.3, preferably 0.1=A=0.2. The main component of a shell is a rare earth manganese oxide, which is as represented by a general formula: RE cMn aO b, wherein RE is a combination of one or more rare earth elements; B is Mn or a combination of Mn and a transition metal element; 1=a=8; 2=b=18; 0.25=c=4. The main component of a core is a cerium-zirconium composite oxide, which is as represented by a general formula: Ce xZr (1-x-y)M yO 2-z, wherein M is one or more non-cerium rare earth elements; 0.1=x=0.9; 0=y=0.3; 0.01=z=0.3. The composite compound improves the oxygen storage capacity of a cerium-zirconium material by means of an interfacial effect so as to improve the conversion rate of a nitrogen oxide.
Patent CA-3134386-A1 (CA)
Title: Systeme et procede de distribution de couverts
Inventor: MITHAL ASHISH K
IPC: A47F1/10
Filed: 2020-03-26
Abstract: La présente invention concerne un mécanisme d'échappement d'un distributeur de couverts qui amène un couvert à tomber d'une pile verticale sur une glissière qui le guide vers une position de distribution. Un canal de glissement et un canal de tête de la glissière peuvent confiner latéralement le couvert. Une surface d'amortissement peut réduire le rebondissement et le désalignement des couverts. Le mécanisme d'échappement peut comprendre au moins trois pivots et/ou un ressort de rappel de bobine. Des distributeurs peuvent être installés dans une base selon n'importe quelle combinaison souhaitée et retenus dans cette dernière par des éléments compatibles tels que des brides et des fentes qui empêchent le basculement du distributeur. Dans des modes de réalisation, des distributeurs individuels peuvent être glissés horizontalement en partie hors de la base pour accéder à des éléments latéraux qui seraient sinon obscurcis par un distributeur voisin. Un indicateur de quantité de couverts peut entrer en contact latéral avec la pile de couverts et peut pivoter pour afficher un signal de niveau faible de couverts lorsque la pile de couverts tombe sous une certaine hauteur d'indicateur.
Patent CA-3135253-A1 (CA)
Inventor: BUEHLER MICHAEL J
IPC: B60R19/14
Filed: 2020-05-01
Abstract: L'invention concerne un atténuateur de collision qui inclut un châssis ayant un premier élément de châssis et un deuxième élément de châssis raccordés de manière rigide à un ensemble charnière dans une configuration avant la collision. Les premier et deuxième châssis sont reliés de manière articulée à l'ensemble charnière dans une configuration de collision. L'ensemble charnière comprend une plaque de dégagement reliée de manière fixe au premier élément de châssis, la plaque de dégagement comprenant une ouverture pour élément de fixation et une fente s'étendant entre l'ouverture pour élément de fixation et un bord de la plaque de dégagement, et un élément de fixation s'étendant à travers l'ouverture pour élément de fixation et reliant la plaque de dégagement au deuxième élément de châssis lorsque les premier et deuxième châssis se trouvent dans la configuration avant la collision. L'invention concerne également un ensemble charnière et un procédé d'utilisation de l'atténuateur de collision.